| abstract |
(57) The present invention provides a method for the manufacture of a medicament for reducing the level of oxidative stress factors such as IL-6, reactive oxygen species (ROS), and adhesion molecules in mammals, including humans. It relates to the use of bacterial strains which produce increased amounts of propionic acid in the intestine, preferably Lactobacillus or Propionibacterium . The medicament can be used to prevent and / or treat chronic inflammatory diseases such as rheumatic diseases and psoriasis. |